Pharmaceutical Business review

US to phase out OTC asthma inhalers citing environmental concerns

The CFCs present in the product deplete the earth’s ozone layer.

The decision follows the Montreal Protocol treaty to stop the use of substances that damage the environment.

In an attempt to help asthma patients through the transition, Teva Respiratory is making asthma product samples available to the patients through healthcare practitioners.

The products which will me made available include ProAir HFA (albuterol sulfate) Inhalation Aerosol (quick-relief albuterol inhaler) and QVAR (beclomethasone dipropionate HFA) Inhalation Aerosol (asthma control inhaler).